Greenrose Acquisition Corp.
Greenrose Acquisition Corp. (GNRSW) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001790665 · GNRSW · OTC · as of Jun 10, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001790665 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Greenrose Acquisition Corp. (OTC: GNRSW) has submitted 179 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001790665, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Greenrose Acquisition Corp.'s most comprehensive regulatory disclosure. The most recent Greenrose Acquisition Corp. 10-K was filed on 2022-04-25 for fiscal year ending 2022. Historical GNRSW 10-K annual reports are available from 2019 through 2022.
Investors researching Greenrose Acquisition Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
GNRSW SEC Filings · 8 questionsGreenrose Acquisition Corp. (GNRSW) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 179 filings and access original documents at no cost. Greenrose Acquisition Corp.'s CIK is 0001790665.